Latest ROE for QSAM Biosciences: -741.42% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-741.42%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
QSAM Biosciences (QSAM) currently reports a ROE of -741.42%. That is below the Materials sector average of 19.44%. Use the charts on this page to explore QSAM Biosciences's ROE history and peer comparisons.
QSAM Biosciences's ROE of -741.42% is lower than the Materials sector average of 19.44%. That is roughly 3914.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but QSAM Biosciences's current -741.42% should be judged against Materials norms (sector average: 19.44%) and against QSAM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -741.42%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 19.44%. From there, open related valuation or income-statement pages for QSAM Biosciences, and consider following QSAM for alerts when major investors trade the stock.
QSAM Biosciences is classified in the Materials sector. On ROE, it currently shows -741.42% versus a sector average near 19.44%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing QSAM with unrelated industries.